TIBOFEM

Share :

Related Products

  • Brand Name: TIBOFEM

  • Generic Name: Tibolone

  • Therapeutic ClassSynthetic Steroid with estrogenic, progestogenic, and androgenic activity

  • Presentation: 2.5 mg film-coated tablets


2. Composition

  • Active Ingredient: Tibolone 2.5 mg

  • Excipients:

    • Lactose monohydrate

    • Maize starch

    • Magnesium stearate

    • Hypromellose


3. Mechanism of Action

Tibolone is metabolized into 3 active compounds:

  1. Δ4-isomer (progestogenic/androgenic effects)

  2. 3α-OH & 3β-OH metabolites (estrogenic effects)

Key Effects: ✔ Relieves menopausal symptoms (hot flashes, vaginal dryness) ✔ Prevents bone loss (osteoporosis) ✔ Endometrial protection (no need for additional progestogen) ✔ Improves libido (mild androgenic activity)


4. Dosage & Administration

  • Standard Dose2.5 mg once daily (oral)

  • Initiation: Start at least 12 months after last menstrual period

  • Missed Dose: Take as soon as remembered (skip if next dose is due)

  • Administration: Can be taken with/without food


5. Indications

✅ Postmenopausal symptom relief (vasomotor, urogenital) ✅ Prevention of osteoporosis in high-risk women ✅ Libido enhancement in postmenopausal women


6. Storage & Stability

  • Temperature: Below 30°C

  • Humidity: Keep in original packaging

  • Shelf Life: 3 years

  • Protection: Avoid moisture


7. Key Recommendations

✔ Not for perimenopausal women (wait ≥1 year after last period) ✔ Monitor breast health annually (mammography as needed) ✔ Assess venous thromboembolism risk before prescribing ✔ Consider non-hormonal alternatives for women with CVD risk


8. Important Safety Notes

⚠ Contraindications: ❌ Active/past hormone-dependent cancers ❌ Undiagnosed vaginal bleeding ❌ History of venous thromboembolism ❌ Severe hepatic disease

⚠ Adverse Effects:

  • Common: Headache, vaginal bleeding, weight gain

  • Serious:

    • Increased risk of stroke in women >60 years

    • Possible breast cancer risk (similar to other HRT)

⚠ Drug Interactions:

  • Strong CYP3A4 inducers (e.g., rifampicin) → reduced efficacy

  • Anticoagulants → may require dose adjustment


9. Comparison with Traditional HRT

Parameter TIBOFEM Estrogen+Progestogen HRT
Endometrial Protection Built-in Requires progestogen
Bleeding Profile Spotting common Regular withdrawal bleeding
Libido Effect Positive (androgenic) Neutral/negative
VTE Risk Lower than oral HRT Higher

10. Patient Counseling

✔ Take at the same time daily for consistent effects ✔ Report unusual vaginal bleeding immediately ✔ Attend regular breast/gynecological check-ups ✔ Combine with calcium/vitamin D for bone health


Conclusion

TIBOFEM offers unique tissue-selective benefits for postmenopausal women, combining symptom relief, bone protection, and libido support in a single tablet. However, it requires careful patient selection and monitoring due to potential risks.

  • Brand Name: TIBOFEM

  • Generic Name: Tibolone

  • Therapeutic ClassSynthetic Steroid with estrogenic, progestogenic, and androgenic activity

  • Presentation: 2.5 mg film-coated tablets


2. Composition

  • Active Ingredient: Tibolone 2.5 mg

  • Excipients:

    • Lactose monohydrate

    • Maize starch

    • Magnesium stearate

    • Hypromellose


3. Mechanism of Action

Tibolone is metabolized into 3 active compounds:

  1. Δ4-isomer (progestogenic/androgenic effects)

  2. 3α-OH & 3β-OH metabolites (estrogenic effects)

Key Effects:
✔ Relieves menopausal symptoms (hot flashes, vaginal dryness)
✔ Prevents bone loss (osteoporosis)
✔ Endometrial protection (no need for additional progestogen)
✔ Improves libido (mild androgenic activity)


4. Dosage & Administration

  • Standard Dose2.5 mg once daily (oral)

  • Initiation: Start at least 12 months after last menstrual period

  • Missed Dose: Take as soon as remembered (skip if next dose is due)

  • Administration: Can be taken with/without food


5. Indications

✅ Postmenopausal symptom relief (vasomotor, urogenital)
✅ Prevention of osteoporosis in high-risk women
✅ Libido enhancement in postmenopausal women


6. Storage & Stability

  • Temperature: Below 30°C

  • Humidity: Keep in original packaging

  • Shelf Life: 3 years

  • Protection: Avoid moisture


7. Key Recommendations

✔ Not for perimenopausal women (wait ≥1 year after last period)
✔ Monitor breast health annually (mammography as needed)
✔ Assess venous thromboembolism risk before prescribing
✔ Consider non-hormonal alternatives for women with CVD risk


8. Important Safety Notes

⚠ Contraindications:
❌ Active/past hormone-dependent cancers
❌ Undiagnosed vaginal bleeding
❌ History of venous thromboembolism
❌ Severe hepatic disease

⚠ Adverse Effects:

  • Common: Headache, vaginal bleeding, weight gain

  • Serious:

    • Increased risk of stroke in women >60 years

    • Possible breast cancer risk (similar to other HRT)

⚠ Drug Interactions:

  • Strong CYP3A4 inducers (e.g., rifampicin) → reduced efficacy

  • Anticoagulants → may require dose adjustment


9. Comparison with Traditional HRT

Parameter TIBOFEM Estrogen+Progestogen HRT
Endometrial Protection Built-in Requires progestogen
Bleeding Profile Spotting common Regular withdrawal bleeding
Libido Effect Positive (androgenic) Neutral/negative
VTE Risk Lower than oral HRT Higher

10. Patient Counseling

✔ Take at the same time daily for consistent effects
✔ Report unusual vaginal bleeding immediately
✔ Attend regular breast/gynecological check-ups
✔ Combine with calcium/vitamin D for bone health


Conclusion

TIBOFEM offers unique tissue-selective benefits for postmenopausal women, combining symptom relief, bone protection, and libido support in a single tablet. However, it requires careful patient selection and monitoring due to potential risks.

We offer a variety of shipping options, including Express Mail Service (EMS), USPS, DHL, FedEx, TNT, UPS, Aramex, Air Cargo, and sea freight.

Terms and Conditions – 

Bulk Orders: You are responsible for any local import duties and taxes in your country.

For Patients: When ordering prescription medicines for personal use, or for a friend or relative, a valid medical practitioner’s script or prescription is required.

Return and Refund Policy: Due to the nature of our products, we cannot accept returns or exchanges once a purchase is made. However, in the event of non-delivery, you are eligible for either a 100% refund or a reshipment of your order.

  • Brand Name: TIBOFEM

  • Generic Name: Tibolone

  • Therapeutic ClassSynthetic Steroid with estrogenic, progestogenic, and androgenic activity

  • Presentation: 2.5 mg film-coated tablets


2. Composition

  • Active Ingredient: Tibolone 2.5 mg

  • Excipients:

    • Lactose monohydrate

    • Maize starch

    • Magnesium stearate

    • Hypromellose


3. Mechanism of Action

Tibolone is metabolized into 3 active compounds:

  1. Δ4-isomer (progestogenic/androgenic effects)

  2. 3α-OH & 3β-OH metabolites (estrogenic effects)

Key Effects:
✔ Relieves menopausal symptoms (hot flashes, vaginal dryness)
✔ Prevents bone loss (osteoporosis)
✔ Endometrial protection (no need for additional progestogen)
✔ Improves libido (mild androgenic activity)


4. Dosage & Administration

  • Standard Dose2.5 mg once daily (oral)

  • Initiation: Start at least 12 months after last menstrual period

  • Missed Dose: Take as soon as remembered (skip if next dose is due)

  • Administration: Can be taken with/without food


5. Indications

✅ Postmenopausal symptom relief (vasomotor, urogenital)
✅ Prevention of osteoporosis in high-risk women
✅ Libido enhancement in postmenopausal women


6. Storage & Stability

  • Temperature: Below 30°C

  • Humidity: Keep in original packaging

  • Shelf Life: 3 years

  • Protection: Avoid moisture


7. Key Recommendations

✔ Not for perimenopausal women (wait ≥1 year after last period)
✔ Monitor breast health annually (mammography as needed)
✔ Assess venous thromboembolism risk before prescribing
✔ Consider non-hormonal alternatives for women with CVD risk


8. Important Safety Notes

⚠ Contraindications:
❌ Active/past hormone-dependent cancers
❌ Undiagnosed vaginal bleeding
❌ History of venous thromboembolism
❌ Severe hepatic disease

⚠ Adverse Effects:

  • Common: Headache, vaginal bleeding, weight gain

  • Serious:

    • Increased risk of stroke in women >60 years

    • Possible breast cancer risk (similar to other HRT)

⚠ Drug Interactions:

  • Strong CYP3A4 inducers (e.g., rifampicin) → reduced efficacy

  • Anticoagulants → may require dose adjustment


9. Comparison with Traditional HRT

Parameter TIBOFEM Estrogen+Progestogen HRT
Endometrial Protection Built-in Requires progestogen
Bleeding Profile Spotting common Regular withdrawal bleeding
Libido Effect Positive (androgenic) Neutral/negative
VTE Risk Lower than oral HRT Higher

10. Patient Counseling

✔ Take at the same time daily for consistent effects
✔ Report unusual vaginal bleeding immediately
✔ Attend regular breast/gynecological check-ups
✔ Combine with calcium/vitamin D for bone health


Conclusion

TIBOFEM offers unique tissue-selective benefits for postmenopausal women, combining symptom relief, bone protection, and libido support in a single tablet. However, it requires careful patient selection and monitoring due to potential risks.

Reviews

There are no reviews yet.

Be the first to review “TIBOFEM”

Your email address will not be published. Required fields are marked *

  • Brand Name: TIBOFEM

  • Generic Name: Tibolone

  • Therapeutic ClassSynthetic Steroid with estrogenic, progestogenic, and androgenic activity

  • Presentation: 2.5 mg film-coated tablets


2. Composition

  • Active Ingredient: Tibolone 2.5 mg

  • Excipients:

    • Lactose monohydrate

    • Maize starch

    • Magnesium stearate

    • Hypromellose


3. Mechanism of Action

Tibolone is metabolized into 3 active compounds:

  1. Δ4-isomer (progestogenic/androgenic effects)

  2. 3α-OH & 3β-OH metabolites (estrogenic effects)

Key Effects:
✔ Relieves menopausal symptoms (hot flashes, vaginal dryness)
✔ Prevents bone loss (osteoporosis)
✔ Endometrial protection (no need for additional progestogen)
✔ Improves libido (mild androgenic activity)


4. Dosage & Administration

  • Standard Dose2.5 mg once daily (oral)

  • Initiation: Start at least 12 months after last menstrual period

  • Missed Dose: Take as soon as remembered (skip if next dose is due)

  • Administration: Can be taken with/without food


5. Indications

✅ Postmenopausal symptom relief (vasomotor, urogenital)
✅ Prevention of osteoporosis in high-risk women
✅ Libido enhancement in postmenopausal women


6. Storage & Stability

  • Temperature: Below 30°C

  • Humidity: Keep in original packaging

  • Shelf Life: 3 years

  • Protection: Avoid moisture


7. Key Recommendations

✔ Not for perimenopausal women (wait ≥1 year after last period)
✔ Monitor breast health annually (mammography as needed)
✔ Assess venous thromboembolism risk before prescribing
✔ Consider non-hormonal alternatives for women with CVD risk


8. Important Safety Notes

⚠ Contraindications:
❌ Active/past hormone-dependent cancers
❌ Undiagnosed vaginal bleeding
❌ History of venous thromboembolism
❌ Severe hepatic disease

⚠ Adverse Effects:

  • Common: Headache, vaginal bleeding, weight gain

  • Serious:

    • Increased risk of stroke in women >60 years

    • Possible breast cancer risk (similar to other HRT)

⚠ Drug Interactions:

  • Strong CYP3A4 inducers (e.g., rifampicin) → reduced efficacy

  • Anticoagulants → may require dose adjustment


9. Comparison with Traditional HRT

Parameter TIBOFEM Estrogen+Progestogen HRT
Endometrial Protection Built-in Requires progestogen
Bleeding Profile Spotting common Regular withdrawal bleeding
Libido Effect Positive (androgenic) Neutral/negative
VTE Risk Lower than oral HRT Higher

10. Patient Counseling

✔ Take at the same time daily for consistent effects
✔ Report unusual vaginal bleeding immediately
✔ Attend regular breast/gynecological check-ups
✔ Combine with calcium/vitamin D for bone health


Conclusion

TIBOFEM offers unique tissue-selective benefits for postmenopausal women, combining symptom relief, bone protection, and libido support in a single tablet. However, it requires careful patient selection and monitoring due to potential risks.

Reviews

There are no reviews yet.

Be the first to review “TIBOFEM”

Your email address will not be published. Required fields are marked *

Medical Disclaimer

Anteka Pharmacy primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on Anteka Pharmacy. Our mission is to support, not replace, the doctor-patient relationship.
Scroll to Top

Log in

Create an Account

Send Enquiry For TIBOFEM